JayMac Pharmaceuticals, LLC Report issue

For profit
Founded: Sunset LA United States (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2016
NCT02676882
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

JayMac Pharmaceuticals, LLC

Active Ingredients

Drugs in Other Trials (1)

folic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 4)

Mood Disorders (Phase 4)

Premenstrual Dysphoric Disorder (Phase 4)

Premenstrual Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1